Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Techniques for accurate diagnosis of primary sclerosing cholangitis

This month's Clinical Gastroenterology & Hepatology shows that magnetic resonance cholangiography and endoscopic retrograde cholangiography performed equally well in the accurate diagnosis of primary sclerosing cholangitis.

News image

fiogf49gjkf04

Dr Audun Berstad and colleagues from Norway evaluated the accuracy, and interobserver variability of 2 techniques in the diagnosis of primary sclerosing cholangitis.

The research team compared magnetic resonance cholangiography with endoscopic retrograde cholangiography.

The team performed magnetic resonance cholangiography at 1.5 T with thin- and thick-slice breath-hold technique in 66 adult patients, of which 26 were women.

The median age of the patients was 44 years, and they presented with an appropriate spectrum of hepatobiliary diseases.

Maximum intensity projection images were reconstructed from the thin slices.

Endoscopic retrograde cholangiography was performed within 48 hours of the magnetic resonance examination.

The reference standard of primary sclerosing cholangitis diagnosis was based on a combination of clinical features and cholestatic biochemical profile.

The team used typical abnormal findings of endoscopic retrograde cholangiography and/or magnetic resonance cholangiography.

These were supported by liver histology findings.

The images were retrospectively analyzed by 2 independent reviewers who were unaware of the final diagnoses.

Endoscopic retrograde cholangiography had an accuracy of 85%
Clinical Gastroenterology & Hepatology

The researchers diagnosed primary sclerosing cholangitis in 59% of patients.

Magnetic resonance cholangiography provided comparable and poorer depiction than endoscopic retrograde cholangiography of extrahepatic and intrahepatic ducts, respectively.

However, the the team noted that diagnostic accuracy of endoscopic retrograde cholangiography and magnetic resonance cholangiography were comparable.

In the magnetic resonance cholangiography detection of primary sclerosing cholangitis, the average sensitivity of 2 independent readers was 80%.

The research team noted that with magnetic resonance, specificity was 87%, and the accuracy was 83%.

The corresponding values for endoscopic retrograde cholangiography were a sensitivity of 89%, a specificity of 80%, and an accuracy of 85%.

The researchers found that interobserver agreement for the diagnosis of primary sclerosing cholangitis was good for magnetic resonance cholangiography.

Interobserver agreement for endoscopic retrograde cholangiography was excellent.

Dr Berstad's team concluded, “Primary sclerosing cholangitis can be diagnosed with high accuracy and good interobserver agreement.”

“Magnetic resonance cholangiography and endoscopic retrograde cholangiography performed equally well in the diagnosis of primary sclerosing cholangitis when used blinded to clinical information.”

Clin Gastroenterol Hepatol 2006: 4(4): 514-20
19 April 2006

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us